跳至主要内容
临床试验/JPRN-UMIN000026160
JPRN-UMIN000026160已完成未知

The systematical review a functionality participation ingredient "psyllium" exerts on constipated improvement - The systematical review a functionality participation ingredient "psyllium" exerts on constipated improvement

Adaptgen Pharmaceutical Co., Ltd. Sales Planning Division & Clinical development division0 个研究点目标入组 1 人开始时间: 2017年2月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1

研究概览

简要总结

By ingesting a food-derived functional involved component "psyllium", continuous ingestion of RQ / CQ "food-derived functional component psyllium" defined in this SR research review improved constipation compared with the control group Do you let it? "The continuous use of psyllium improves the frequency of defecation, the number of days of defecation, the amount of defecation and improves constipation tendency", and "usage, dosage" confirmed efficacy and safety are as follows I came to the conclusion. 1. Effect to improve stool frequency (Direction) Once a day / 2 times / day / day (Dose) 4.0 g / day to 8.0 g / day per day 2. The effect of improving defecation days (Direction) Once a day / 2 times / day / day (Dose) 4.0 g / day to 8.0 g / day per day 3. Effect to improve defecation volume (Direction) Once a day / 2 times / day / day (Dose) 4.0 g / day to 8.0 g / day per day

研究设计

研究类型
Others,meta-analysis etc

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • [Exclusion Criteria] In the secondary screening, provisional candidate documents are obtained by the abstract, and those corresponding to one or more of the following exclusion criteria are excluded from the candidate literature. 1.Clinical research literature for subjects suffering from gastrointestinal and gastrointestinal diseases 2.Clinical research literature for minors 3.Literature of clinical research for pregnant women and lactating women 4.Clinical research literature not reviewed 5.Literature of clinical study without comparative control group 6.Clinical research literature in which the main involved component is not psylium 7.Clinical research literature which can not be evaluated by glucosylceramide and other equivalent ingredients 8.In addition, clinical research literature judged inappropriate by the reviewer's agreement

研究者

发起方
Adaptgen Pharmaceutical Co., Ltd. Sales Planning Division & Clinical development division

相似试验